Non-TNF-Targeted Biologic vs a Second Anti-TNF Drug to Treat Rheumatoid Arthritis in Patients With Insufficient Response to a First Anti-TNF Drug: A Randomized Clinical Trial.
暂无分享，去创建一个
P. Ravaud | X. Mariette | J. Gottenberg | A. Saraux | L. Chatenoud | J. Sibilia | J. Berthelot | M. Breban | O. Meyer | J. Morel | B. Fautrel | D. Wendling | A. Constantin | P. Claudepierre | J. Sellam | Y. Pers | É. Perrodeau | C. Marcelli | C. Zarnitsky | S. Rist | A. Perdriger | O. Vittecoq | E. Dernis | O. Fain | F. Lioté | J. Salmon | M. Soubrier | I. Chary-Valckenaere | H. Marotte | C. Richez | S. Candon | S. Guis | E. Solau-Gervais | J. Ziza | S. Lassoued | M. Gayraud | C. Bonnet | J. Balblanc | L. Euller-Ziegler | G. Cormier | M. Gilson | O. Brocq | M. Ardizzone | Ouafaa Aberkane | C. Back | G. Bolla | Marion Vazel | L. Euller‐Ziegler | J. Morel